Posts tagged “Local Firms”
Lenovo earnings soar 54%, revenues climb 44% to record $8.4B
The world's No. 2 PC maker is confident of closing in on the top spot in PC sales as it reported strong sales growth across all major markets even as it focuses more attention on the burgeoning smartphone and mobile Internet market. Analysts like what they see.
Tracking Lenovo's growth
Epic Games' Tim Sweeney reaps arts Hall of Fame honor today
The founder of the Cary-based videogame industry giant will be inducted into the Academy of Interactive Arts & Sciences Hall of Fame in Las Vegas. It's a truly deserved honor for Sweeney who has built Epic into a technical and financial success.
Durham stem cell firm Aldagen sold for up to $40M
Regenerative medicine company Cytomedix has acquired the venture-capital backed company in a $16 million stock deal plus millions more in stock options. Aldagen investors include Intersouth and Aurora Funds.
A purified STEM cell
Diagnostic labs in High Point to add up to 500 jobs
"High Point was a natural fit for our expansion," Solstas Chief Executive David Weavil says. "Simply put, the energy and experience of the medical workforce here is exceptional and meets our needs for a best-in-class organization."
Siemens, GSK joint venture team for personalized diagnostic drug tests
An HIV/AIDS treatment developed by GlaxoSmithKline is now being studied with Siemens to develop companion diagnostics that doctors can use to select patients appropriate for the treatment.
Tech briefs: New Clinipace exec; Pfizer picks Biologics; Bronto marketing whitepaper; new Telit deal; ChannelAdvisor client win; Mariner training
Triangle Capital looks to raise $67M in stock offering
The Raleigh-based firm focuses on lower middle market companies, which the firm defines as companies with revenues between $10 million and $100 million and earnings between $3 and $20 million.
Co-founder of CoLucid Pharmaceuticals in Durham dies
Dr. James White, a long-time pharmaceutical executive, launched CoLucid in 2005 along with Art Pappas of Pappas Ventures in Durham.
Tale of two drug giants: GSK's pipeline full, AstraZeneca's dwindles
Analysis: While AstraZeneca cuts, GSK is putting itself in a position to discover, develop and position for approval of a wider array of potential drug candidates. It's a strategy that should pay off in the best of times, and the worst of times.
Drug research
Lenovo defends 'relationship' with former Acer CEO
Gianfranco Lanci, who was hired by the world's No. 2 PC manufacturer to spearhead growth efforts in Europe, violated a non-compete agreement, says Taiwan-based Acer. Acer sued Lanci on Tuesday.
Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
Inside the Bulldog blog: Red Hat's new Fedora project lead focusing on 'cloud;' Cree claims bid advance on LEDs in price, performance; Greenpeace lists Google, Cisco as top "Cool IT" firms; Oracle says no to $272M settlement in SAP lawsuit; Yahoo's chairman is out.
It's RHT: Red Hat plans to rename new HQ 'Red Hat Tower'
Progress Energy plans to vacate the 19-story downtown tower as part of a merger with Charlotte-based Duke Energy. Red Hat is already preparing for the move into space being customized "for the needs and culture of Red Hat."
GSK is back in the black but reason to cheer?
Chief Executive Officer Andrew Witty used the quarterly performance to tout his performance as CEO and multiple advances in the drug giant's product pipeline. However, two analysts are cautious about the news.
GSK Headquarters
Salix drug receives priority FDA review, but partner wants it back
The Raleigh firm is tied up in a law suit over the development of the drug that's intended to help AIDS patients suffering with diarrhea.
RTP broadband firm Overture, minus two top execs, launches new look
The global provider of Ethernet related broadband services shortens its name, creates a new logo and revamps its websites. The changes come in the post-Hatteras Network merger, and among the recent moves is the departure of the former Hatteras CEO.
Overture's new logo
